Abstract.
Proinsulin has generally been regarded as an inert precursor to insulin. However, over the past few years, proinsulin has established itself as a useful research tool for understanding how cells synthesize and secrete peptide hormones. Last year, proinsulin attracted renewed interest for its role as the precursor to C peptide, which may prove useful in the treatment of patients suffering from insulin-dependent diabetes mellitus. This mini-review focuses on three aspects of proinsulin, each of which attracted attention in 1997. These three aspects illustrate how this peptide hormone precursor may yet prove to be more important than its primary role as a prohormone, with only one bioactive product, would suggest.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received 4 March 1998; received after revision 4 May 1998; accepted 4 May 1998
Rights and permissions
About this article
Cite this article
Mackin, R. Proinsulin: recent observations and controversies. CMLS, Cell. Mol. Life Sci. 54, 696–702 (1998). https://doi.org/10.1007/s000180050196
Issue Date:
DOI: https://doi.org/10.1007/s000180050196